PARTNERSHIPS

We are seeking strategic partnerships

Oncovir, Inc. is a Biotech company dedicated to the development of Hiltonol® in the clinical areas of solid cancer and infectious disease.

We promote Hiltonol® as an experimental viral mimic and broad activator of innate and adaptive immunity. We have partnered extensively with both commercial companies and academic institutions.

Oncovir manufactues GMP grade clinical material for use in approved regulatory settings and preclinical material suitable for preclinical and scientific exploration

Partnerships can be focused on individual indications in our pipeline or any area of our platform.